Most notably for the present study, recent data implicate DSG2 in regulating the angiogenic activity of ECs, whereby loss of function disrupts tube formation on Matrigel and in vivo neoangiogenesis, and is associated with defective angiogenesis in patients with systemic sclerosis [24] (Ebert et al, submitted). This evidence concerns the gene DSG2 and systemic sclerosis.